Médecine

Paramédical

Autres domaines


S'abonner

Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa - 12/04/19

Doi : 10.1016/j.jaad.2018.09.040 
Sara Wertenteil, BA, Andrew Strunk, MA, Amit Garg, MD
 Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York 

Correspondence to: Amit Garg, MD, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 1991 Marcus Ave, Suite 300, New Hyde Park, NY, 11042.Donald and Barbara Zucker School of Medicine at Hofstra/Northwell1991 Marcus AveSuite 300New Hyde ParkNY11042

Abstract

Background

Evidence establishing a link between acne vulgaris (AV) and hidradenitis suppurativa (HS) is limited, and the burden of AV in adults with HS is unknown.

Objective

To determine the prevalence of AV among adults with HS and determine the strength of this association.

Methods

Cross-sectional analysis identifying adults with AV among patients with and without HS by using electronic health record data from a population-based sample of more than 55 million patients.

Results

The prevalence of AV among adults with HS was 15.2% (7315 of 48,085) compared with 2.9% (497,360 of 16,899,470) for adults without HS (P < .001). The prevalence was greatest among patients with HS who were female (5870 of 35,790 [16.4%]), were 18 to 44 years old (5260 of 28,870 [18.2%]), were nonwhite (3120 of 17,825 [17.5%]), were obese (5430 of 35,135 [15.5%]), and had polycystic ovarian syndrome (685 of 2385 [28.7%]). Patients with HS had 4.51 [95% confidence interval, 4.40-4.63] times the odds of having AV than did patients without HS, with the higher likelihood of having AV persisting across all subgroups of patients with HS. The association between HS and AV was generally stronger for patients who were male, and 65 years of age or older.

Limitations

Influence of disease severity in HS, or in acne, on the strength of the association could not be assessed.

Conclusion

Patients with HS may benefit from assessment of acne status and optimization of comanagement strategies.

Le texte complet de cet article est disponible en PDF.

Key words : acne vulgaris, burden, Explorys, hidradenitis suppurativa, prevalence

Abbreviations used : AV, BMI, CI, HS, ICD, ICD-9, OR, PCOS, PPV, SNOMED-CT


Plan


 Funding sources: Supported in part by an education grant from AbbVie. The sponsor has had no role in the design and conduct of the study; collection, management, analysis and interpretation of data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.
 Disclosure: Dr Garg has served as an advisor for AbbVie, Asana Biosciences, Janssen, Pfizer, and UCB and has received honoraria for his service. Ms Wertenteil and Mr Strunk have no conflicts of interest to disclose.
 Reprints not available from the authors.


© 2018  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 80 - N° 5

P. 1308-1313 - mai 2019 Retour au numéro
Article précédent Article précédent
  • Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: A study of the German Central Malignant Melanoma Registry
  • Maximilian Gassenmaier, Ulrike Keim, Ulrike Leiter, Thomas K. Eigentler, Martin Röcken, Anja Gesierich, Rose K.C. Moritz, Lucie Heinzerling, Thomas Tüting, Uwe Wollina, Claus Garbe
| Article suivant Article suivant
  • Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations
  • Raffaele Dante Caposiena Caro, Maria Vittoria Cannizzaro, Elisabetta Botti, Cosimo Di Raimondo, Eleonora Di Matteo, Roberta Gaziano, Luca Bianchi

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement ou un achat à l’unité.

Déjà abonné à cette revue ?

;

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.